ENDRA Life Sciences (NDRA) EPS (Basic) Growth (5y) (2021 - 2026)
Powered by 
Analysis
ENDRA Life Sciences (NDRA) EPS (Basic) Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.89% |
| Mar 31, 2026 | 55.59% |
| Dec 31, 2025 | 49.05% |
| Sep 30, 2025 | 57.60% |
| Jun 30, 2025 | 61.28% |
| Mar 31, 2025 | 63.55% |
| Dec 31, 2024 | 62.80% |
| Sep 30, 2024 | 53.93% |
| Jun 30, 2024 | 58.05% |
| Mar 31, 2024 | 48.95% |
| Dec 31, 2023 | 53.46% |
| Sep 30, 2023 | 50.83% |
| Jun 30, 2023 | 46.15% |
| Mar 31, 2023 | 42.21% |
| Dec 31, 2022 | 41.53% |
| Sep 30, 2022 | 25.20% |
| Jun 30, 2022 | 37.01% |
| Mar 31, 2022 | 42.16% |
| Dec 31, 2021 | 39.72% |
| Sep 30, 2021 | 45.77% |